The Case for Minimally-Invasive Hepatic Microwave Ablation
After viewing the webinar, please go to http://www.saxetesting.com/init/ where you may log in and register. Once you have completed the test, you may download your certificate.
Microwave ablation (MWA) of hepatic malignancies is an effective treatment strategy for patients unable to tolerate definitive resection or transplantation. The laparoscopic approach is an underutilized technique and prognostic factors of survival in this setting are not well characterized. The aim of this webinar will be to present optimal approaches and techniques to consider regarding, patient selection, tumor location, and other prognostic factors for MWA.
Upon completion of this educational activity, the participant will be able to:
Describe hepatic microwave ablation in the surgical setting through review of evidence-based medicine, and expert practice
Discuss the minimal standards of ultrasound equipment needed to perform non-resectable tumor ablation
Recognize the optimal quality standards for non-resectable liver tumor ablation
* On-demand version available on May 4th, 2021
D. Martin II is the Sam & Lolita Weakley Endowed Chair in Surgical Oncology,
Vice-Chair of the Department of Surgery for Research, Director, Division of Surgical Oncology, Professor of Surgeryand Director, Upper GI & HPB Multi-Disciplinary Clinic Academic Advisory Dean at the
University of Louisville. His clinical interests focus on the multiple disciplinary care and surgical management of patients with upper gastrointestinal malignancies. His research focuses on genetic predispositions to upper gastrointestinal malignancies. Dr. Martin has served as principal investigator or co-investigator in numerous trials. He has written or co-written many articles, book chapters, and abstracts and is a frequent invited lecturer.
Continuing Education for Physicians and Nurses
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and Saxe Healthcare Communications. SynAptiv is accredited by ACCME for 1 AMA PRA Category 1 Credit.
This education activity is approved for 1.0 contact hour. Provider Saxe Healthcare Communications approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.